Dr. Angelo Kim, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 38600 Medical Center Drive,, Palmdale, CA 93551 Phone: 661-382-5000 |
Sania Zubair, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 38600 Medical Center Dr, Palmdale, CA 93551 Phone: 661-382-5000 |
Dr. Feyi Nneka Emembolu, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 38600 Medical Center Dr, Palmdale, CA 93551 Phone: 661-382-6000 |
Raymond Ryan Navarro Ruiz, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 38600 Medical Center Dr, Palmdale, CA 93551 Phone: 915-545-7345 Fax: 915-545-7338 |
News Archive
Republicans controlled all the levers of government in a staggering number of states this year — and it showed. Holding a lock on the governorship and both houses of the legislature in 20 states, GOP conservatives advanced an agenda that may change the face of state government for decades. They honored pledges not to raise taxes by enacting huge spending cuts to balance budgets in Florida and Texas.
By turning skin cells into brain neurons, researchers at the Icahn School of Medicine at Mount Sinai have identified that certain tiny molecules aiding in gene expression, known as microRNAs (miRNAs), are under-expressed in the brains of the 14 schizophrenia patients they studied. Their findings, published online today in the journal Cell Reports, show that one of these molecules, a miRNA known as miR-9, is a risk factor that controls the activity of hundreds of genes.
Saint Vincent Hospital today announced it has signed a purchase and sale agreement with the CitySquare II Development Co. LLC , to build a medical office building that will house a new comprehensive cancer center in Worcester's CitySquare development. The new center, which represents a $21 million capital investment by Saint Vincent Hospital, is expected to open in January 2013.
Cedars-Sinai scientists have joined with expert colleagues around the globe in using stem cells to develop a laboratory model for Huntington's disease, allowing researchers for the first time to test directly on human cells potential treatments for this fatal, inherited disorder.
PTC Therapeutics, Inc. (PTC) today announced that it has reached a major research milestone in its collaboration with Schering-Plough Corporation (NYSE: SGP) receiving a $2 million payment in connection with the designation of a development candidate for the treatment of hepatitis C virus (HCV) infection.
› Verified 4 days ago